Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05067387 · ClinicalTrials.gov registry record · Phase 1
Evaluation of Oral THC and CBD in Men and Women
A Phase 1 study, sponsored by University of California, Los Angeles.
- Not yet
- Registry status
- Phase 1
- Development phase
- 22
- Enrollment target
NCT05067387 is a Phase 1 study that has not yet begun recruiting, run by University of California, Los Angeles. The registered enrollment target is 22 participants.
The verdict
NCT05067387, a Phase 1 study, has not yet begun recruiting, sponsored by University of California, Los Angeles.
- NOT YET RECRUITING
- Registry status
- Phase 1
- Development phase
- 22 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the pharmacokinetics and pharmacodynamics of oral delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) and to evaluate detection of recently smoked THC in oral fluid.
Interventions
- DRUG Placebo
- DRUG THC
- DRUG CBD
- DRUG THC + CBD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2026-07-15 |
| Est. Completion | 2028-06-15 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05067387
The ClinicalTrials.gov registry entry for NCT05067387 describes a study currently listed as not yet recruiting, categorized as Phase 1. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT05067387 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05067387 about?
NCT05067387 is a clinical study titled "Evaluation of Oral THC and CBD in Men and Women". The purpose of this study is to determine the pharmacokinetics and pharmacodynamics of oral delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) and to evaluate detection of recently smoked THC in oral fluid.
What is the current status of trial NCT05067387?
This trial is currently not yet recruiting. It is a Phase 1 study. The enrollment target is 22 participants. The study started on 2026-07-15. Estimated completion is 2028-06-15.
What interventions are being tested in trial NCT05067387?
The interventions under investigation include: Placebo (DRUG), THC (DRUG), CBD (DRUG), THC + CBD (DRUG).
Who is sponsoring clinical trial NCT05067387?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.